Liudmila Zhaunova

Liudmila Zhaunova

Auto-generated profile, based on publicly available information

Liudmila Zhaunova

Flo Health Inc., London, UK

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
ACAdam C Cunningham
Adam C Cunningham
CPCarley Prentice
Carley Prentice
KPKimberly Peven
Kimberly Peven
AWAidan Wickham
Aidan Wickham
RBRyan Bamford
Ryan Bamford
SPSonia Ponzo
Sonia Ponzo
Background: Reproductive health literacy and menstrual health awareness play a crucial role in ensuring the health and well-being of women and people who menstruate. Further, awareness of one’s own menstrual cycle patterns and associated symptoms can help individuals identify and manage conditions of the menstrual cycle such as premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Digital health products, and specifically menstrual health apps, have the potential to effect positive change due to their scalability and ease of access. Objective: The primary aim of this study was to measure the efficacy of a menstrual and reproductive health app, Flo, in improving health literacy and health and well-being outcomes in menstruating individuals with and without PMS and PMDD. Further, we explored the possibility that the use of the Flo app could positively influence feelings around reproductive health management and communication about health, menstrual cycle stigma, unplanned pregnancies, quality of life, work productivity, absenteeism, and body image. Methods: We conducted 2 pilot, 3-month, unblinded, 2-armed, remote randomized controlled trials on the effects of using the Flo app in a sample of US-based (1) individuals who track their cycles (n=321) or (2) individuals who track their cycles and are affected by PMS or PMDD (n=117). Results: The findings revealed significant improvements at the end of the study period compared to baseline for our primary outcomes of health literacy (cycle tracking: D̄=1.11; t311=5.73, P<.001; PMS or PMDD: D̄=1.20; t115=3.76, P<.001) and menstrual health awareness (D̄=3.97; t311=7.71, P<.001), health and well-being (D̄=3.44; t311=5.94, P<.001), and PMS or PMDD symptoms burden (D̄=–7.08; t115=–5.44, P<.001). Improvements were also observed for our secondary outcomes of feelings of control and management over health (D̄=1.01; t311=5.08, P<.001), communication about health (D̄=0.93; t311=2.41, P=.002), menstrual cycle stigma (D̄=–0.61; t311=–2.73, P=.007), and fear of unplanned pregnancies (D̄=–0.22; t311=–2.11, P=.04) for those who track their cycles, as well as absenteeism from work and education due to PMS or PMDD (D̄=–1.67; t144=–2.49, P=.01). Conclusions: These pilot randomized controlled trials demonstrate that the use of the Flo app improves menstrual health literacy and awareness, general health and well-being, and PMS or PMDD symptom burden. Considering the widespread use and affordability of the Flo app, these findings show promise for filling important gaps in current health care provisioning such as improving menstrual knowledge and health. Trial Registration: OSF Registries osf.io/pcgw7; https://osf.io/pcgw7 ; OSF Registries osf.io/ry8vq; https://osf.io/ry8vq

26 April 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
LZLiudmila Zhaunova
Liudmila Zhaunova
RBRyan Bamford
Ryan Bamford
TRTara Radovic
Tara Radovic
AWAidan Wickham
Aidan Wickham
KPKimberly Peven
Kimberly Peven
SPSonia Ponzo
Sonia Ponzo
Background: Research shows that poor knowledge and awareness of menstrual and pregnancy health among women are associated with adverse reproductive health and pregnancy outcomes. Menstrual cycle– and pregnancy-tracking mobile apps are promising tools for improving women’s awareness of and attitudes toward their reproductive health; however, there is little information about subscribers’ perceptions of app functionality and its impact on their knowledge and health. Objective: This study aimed to explore knowledge and health improvements related to menstrual cycle and pregnancy, as well as improvements in general health among Flo app users. We also investigated what components of the Flo app were associated with the abovementioned improvements and evaluated whether those improvements differed based on education level, country of residence (low- and middle-income vs high-income countries), free or premium subscription to the app, short- or long-term use of the app, and frequency of use. Methods: Flo subscribers who had been using the app for no less than 30 days, completed a web-based survey. A total of 2212 complete survey responses were collected. The survey included demographic questions and questions about motivations guiding the use of the Flo app and which components of the app improved their knowledge and health, as well as to what extent. Results: Most study participants reported improvements in menstrual cycle (1292/1452, 88.98%) and pregnancy (698/824, 84.7%) knowledge from Flo app use. Participants with higher levels of education and those from high-income countries reported using the app predominantly for getting pregnant (χ21=4.2, P=.04; χ21=52.3, P<.001, respectively) and pregnancy tracking (χ21=19.3, P<.001; χ21=20.9, P=.001, respectively). Participants with less education reported using the app to avoid pregnancy (χ21=4.2; P=.04) and to learn more about their body (χ21=10.8; P=.001) and sexual health (χ21=6.3; P=.01), while participants from low- and middle-income countries intended to mainly learn more about their sexual health (χ21=18.2; P<.001). Importantly, the intended use of the app across education levels and country income levels matched areas in which they had gained knowledge and achieved their health goals upon use of the Flo app. Period, fertile days, and ovulation predictions as well as symptom tracking were consistently the top 3 components in the app that helped users with their cycle knowledge and general health. Reading articles or watching videos helped with users' education regarding their pregnancy. Finally, the strongest improvements in knowledge and health were observed in premium, frequent, and long-term users. Conclusions: This study suggests that menstrual health apps, such as Flo, could present revolutionary tools to promote consumer health education and empowerment on a global scale.

5 December 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
KPKimberly Peven
Kimberly Peven
AWAidan P Wickham
Aidan P Wickham
OWOctavia Wilks
Octavia Wilks
YKYusuf C Kaplan
Yusuf C Kaplan
AMAndrei Marhol
Andrei Marhol
LZLiudmila Zhaunova
Liudmila Zhaunova
Background: Reproductive health conditions such as endometriosis, uterine fibroids, and polycystic ovary syndrome (PCOS) affect a large proportion of women and people who menstruate worldwide. Prevalence estimates for these conditions range from 5% to 40% of women of reproductive age. Long diagnostic delays, up to 12 years, are common and contribute to health complications and increased health care costs. Symptom checker apps provide users with information and tools to better understand their symptoms and thus have the potential to reduce the time to diagnosis for reproductive health conditions. Objective: This study aimed to evaluate the agreement between clinicians and 3 symptom checkers (developed by Flo Health UK Limited) in assessing symptoms of endometriosis, uterine fibroids, and PCOS using vignettes. We also aimed to present a robust example of vignette case creation, review, and classification in the context of predeployment testing and validation of digital health symptom checker tools. Methods: Independent general practitioners were recruited to create clinical case vignettes of simulated users for the purpose of testing each condition symptom checker; vignettes created for each condition contained a mixture of condition-positive and condition-negative outcomes. A second panel of general practitioners then reviewed, approved, and modified (if necessary) each vignette. A third group of general practitioners reviewed each vignette case and designated a final classification. Vignettes were then entered into the symptom checkers by a fourth, different group of general practitioners. The outcomes of each symptom checker were then compared with the final classification of each vignette to produce accuracy metrics including percent agreement, sensitivity, specificity, positive predictive value, and negative predictive value. Results: A total of 24 cases were created per condition. Overall, exact matches between the vignette general practitioner classification and the symptom checker outcome were 83% (n=20) for endometriosis, 83% (n=20) for uterine fibroids, and 88% (n=21) for PCOS. For each symptom checker, sensitivity was reported as 81.8% for endometriosis, 84.6% for uterine fibroids, and 100% for PCOS; specificity was reported as 84.6% for endometriosis, 81.8% for uterine fibroids, and 75% for PCOS; positive predictive value was reported as 81.8% for endometriosis, 84.6% for uterine fibroids, 80% for PCOS; and negative predictive value was reported as 84.6% for endometriosis, 81.8% for uterine fibroids, and 100% for PCOS. Conclusions: The single-condition symptom checkers have high levels of agreement with general practitioner classification for endometriosis, uterine fibroids, and PCOS. Given long delays in diagnosis for many reproductive health conditions, which lead to increased medical costs and potential health complications for individuals and health care providers, innovative health apps and symptom checkers hold the potential to improve care pathways.

12 December 2024 in JMIR Formative Research
Verified
Journal Article
Open access
AWAidan P Wickham
Aidan P Wickham
YMYella Martin
Yella Martin
FGFrederick Goddard
Frederick Goddard
ARAllison K Rodgers
Allison K Rodgers
ACAdam C Cunningham
Adam C Cunningham
LZLiudmila Zhaunova
Liudmila Zhaunova
Background: Reproductive health conditions such as polycystic ovary syndrome (PCOS), endometriosis, and uterine fibroids pose a significant burden to people who menstruate, health care systems, and economies. Despite clinical guidelines for each condition, prolonged delays in diagnosis are commonplace, resulting in an increase to health care costs and risk of health complications. Symptom checker apps have the potential to significantly reduce time to diagnosis by providing users with health information and tools to better understand their symptoms. Objective: This study aims to study the prevalence and predictive importance of self-reported symptoms of PCOS, endometriosis, and uterine fibroids, and to explore the efficacy of 3 symptom checkers (developed by Flo Health UK Limited) that use self-reported symptoms when screening for each condition. Methods: Flo’s symptom checkers were transcribed into separate web-based surveys for PCOS, endometriosis, and uterine fibroids, asking respondents their diagnostic history for each condition. Participants were aged 18 years or older, female, and living in the United States. Participants either had a confirmed diagnosis (condition-positive) and reported symptoms retrospectively as experienced at the time of diagnosis, or they had not been examined for the condition (condition-negative) and reported their current symptoms as experienced at the time of surveying. Symptom prevalence was calculated for each condition based on the surveys. Least absolute shrinkage and selection operator regression was used to identify key symptoms for predicting each condition. Participants’ symptoms were processed by Flo’s 3 single-condition symptom checkers, and accuracy was assessed by comparing the symptom checker output with the participant’s condition designation. Results: A total of 1317 participants were included with 418, 476, and 423 in the PCOS, endometriosis, and uterine fibroids groups, respectively. The most prevalent symptoms for PCOS were fatigue (92%), feeling anxious (87%), BMI over 25 (84%); for endometriosis: very regular lower abdominal pain (89%), fatigue (85%), and referred lower back pain (80%); for uterine fibroids: fatigue (76%), bloating (69%), and changing sanitary protection often (68%). Symptoms of anovulation and amenorrhea (long periods, irregular cycles, and absent periods), and hyperandrogenism (excess hair on chin and abdomen, scalp hair loss, and BMI over 25) were identified as the most predictive symptoms for PCOS, while symptoms related to abdominal pain and the effect pain has on life, bleeding, and fertility complications were among the most predictive symptoms for both endometriosis and uterine fibroids. Symptom checker accuracy was 78%, 73%, and 75% for PCOS, endometriosis, and uterine fibroids, respectively. Conclusions: This exploratory study characterizes self-reported symptomatology and identifies the key predictive symptoms for 3 reproductive conditions. The Flo symptom checkers were evaluated using real, self-reported symptoms and demonstrated high levels of accuracy.

27 May 2022 in PsyArXiv
Verified
Preprint
Open access
SPSonia Ponzo
Sonia Ponzo
AWAidan Wickham
Aidan Wickham
RBRyan Bamford
Ryan Bamford
TRTara Radovic
Tara Radovic
LZLiudmila Zhaunova
Liudmila Zhaunova
JPJennifer Payne
Jennifer Payne
Background: Mood and physical symptoms related to the menstrual cycle greatly affect women’s productivity at work and often lead to absenteeism. However, employer-led initiatives to tackle these issues are lacking. Digital health interventions focused on women’s health (such as the Flo mobile phone app) could help fill this gap given their anonymity, scalability and accessibility. Objective: We aimed to 1) measure the impact of disturbances related to the menstrual cycle on work-related productivity in users of the Flo app; 2) characterize levels of support and benefits women receive in the workplace and 3) explore whether the Flo app could help mitigate the impact of issues related to the menstrual cycle on productivity and absenteeism. Methods: 1867 users of the Flo app participated in a survey exploring 1) the extent to which their menstrual cycle negatively impacts their workplace productivity, including whether menstrual cycle-related symptoms led to absence from work in the previous 12 months; 2) whether Flo users feel supported by their manager and whether they receive specific benefits regarding issues related to their cycle and 3) the role of Flo in the management of menstrual cycle symptoms, preparedness, bodily awareness, openness with others, perceived support and mood.Results: The majority of Flo users reported a moderate to severe impact of their cycle on workplace productivity. 45.2% of the respondents reported absenteeism, with an average of 5.8 days of work missed due to their cycle. 48.4% reported not receiving any support from their manager and 94.6% said they were not provided with any specific benefit for issues related to their menstrual cycle. 75.6% declared they want such benefits. Users stated that the Flo app helped them with the management of menstrual cycle symptoms (68.7%), preparedness and bodily awareness (88.7%), openness with others (52.5%) and feeling supported (77.6%). Furthermore, users who reported the most positive impact of the Flo app were 18-25% less likely to report an impact of their menstrual cycle on their productivity and 12-18% less likely to take days off work for issues related to their cycle.Conclusions: The menstrual cycle can have a significant effect on workplace productivity and absenteeism, and resources available to employees are scarce. Digital health apps, such as the Flo app, could equip individuals with tools to better cope with issues related to their menstrual cycle and facilitate discussions around menstrual health in the workplace.

13 June 2022 in OSF Preprints
Verified
Preprint
Open access
LZLiudmila Zhaunova
Liudmila Zhaunova
RBRyan Bamford
Ryan Bamford
TRTara Radovic
Tara Radovic
AWAidan Wickham
Aidan Wickham
KPKimberly Peven
Kimberly Peven
SPSonia Ponzo
Sonia Ponzo
Introduction: Low health literacy among girls, women, and people who menstruate is associated with worse reproductive health outcomes. Mobile apps promise tools for improving women’s health literacy, however, there is little information about subscribers’ perceptions of app functionality and its impact on their knowledge and health. Objective: This study aimed to explore knowledge and health improvements related to menstrual cycle and pregnancy, as well as improvements in general health in Flo app users. We also investigated what components of the Flo app were associated with the above mentioned improvements, and evaluated whether those improvements differed based on education level, free or a premium subscription to the app, short or long term use of the app, and frequency of use. Methods: Flo subscribers who had been using the app for no less than 30 days completed an online survey. A total of 2214 of complete survey responses were collected. The survey included demographic questions, questions about motivations guiding usage of the Flo app, to what extent and what components of the app may have helped improve their knowledge and health (i.e., reproductive, sexual, physical, mental health, health behaviours, and communication with healthcare providers).Results: Most study participants reported menstrual cycle (89.0%) and pregnancy (84.6%) knowledge improvements from Flo app use. 62.3% of Flo users reported ‘period predictions’ and 72.2% reported ‘reading and/or watching articles and video sources in the app’ helped them feel the most informed about their cycle and pregnancy health. Higher educated, Flo Premium, frequent, and short term app users reported using the app mainly for getting pregnant and pregnancy tracking. Lower educated and long time users reported using the app to learn more about their body, sexual health, irregular cycles and related conditions, and to avoid pregnancy. Importantly, intended uses of the app for both lower and higher educated users matched areas in which they have gained knowledge and achieved their health goals upon the Flo app use. Flo Premium, frequent, and long term users were more likely to report improvements in knowledge and health in all areas they chose to use the app for and even beyond.Conclusion: There is a need to increase reproductive health literacy in the global female population. This study has shown that the use of the period tracking app, Flo, as self-reported by its users, improved their menstrual cycle and pregnancy knowledge and health. Additionally, more frequent, long-term, and Flo Premium users were more likely to report knowledge and health improvements across multiple health areas. Thus, the use of digital health apps, such as the Flo app, should be considered for integration into healthcare systems to increase women’s health literacy in the wider population.